Back

Inclisiran in addition to statin therapy lowers lipoprotein(a) and improves one-year outcomes in young patients with familial hypercholesterolemia and coronary artery disease

9 May 2026 (13:04 - 14:12)
Organised by: Logo
Congress Presentation Part of: ePosters in coronary artery disease (chronic) / chronic coronary syndromes (1) Treatment HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Kaloyan Dyankov

University Hospital Alexandrovska, Sofia (Bulgaria)

6 More presentations in this session

Presentation thumbnail
Effect of intravenous iron on quality of life in older adults with acute coronary syndrome: a phase IV clinical study
Doctor C. Bonanad Lozano (Valencia, ES)
Abstract Slides
Presentation thumbnail
Elevated lipoprotein(a) is highly prevalent in ischaemic heart failure with reduced ejection fraction and shows sex-related differences
Doctor K. Dyankov (Sofia, BG)
Abstract Slides
Presentation thumbnail
Clinical profile and outcomes of young patients with ST-elevation myocardial infarction
Ms A. Costa (Guilhufe, PT)
Abstract Slides
Presentation thumbnail
Cardiac rehabilitation: a key determinant of post-myocardial infarction outcomes
Doctor M. Moura (Porto, PT)
Abstract Slides
Presentation thumbnail
Emergency coronary artery bypass surgery after PCI at hospitals with versus without on-site surgical backup: a systematic review and meta-analysis
Doctor M. Soomro (Karachi, PK)
Abstract Slides

Access the full session

Session thumbnail
ePosters in coronary artery disease (chronic) / chronic coronary syndromes (1)

The Event

Event poster

Heart Failure 2026

9 May 2026 13:04 CET
You may be interested in
thumbnail
Congress Presentation
Boosting secondary prevention: efficacy and adherence of inclisiran in post-acute coronary syndrome very high-risk patients
3 April 2025
thumbnail
Congress Presentation
Lipoprotein (a) cholesterol burden predicts atherosclerotic risk in patients with elevated lipoprotein a
13 April 2023
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024
thumbnail
Congress Presentation
LDL treatment-years: a new paradigm for cardiovascular risk reduction
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources